# NFKBIE
## Overview
NFKBIE encodes IκBε, a negative regulator of NF-κB. Mutations in NFKBIE can disrupt this regulatory function, leading to constitutive activation of NF-κB signaling.<sup>1</sup> Mutations are relatively common in DLBCL and MCL.<sup>2</sup> 

## Relevance tier by entity

|Entity|Tier|Description               |
|:------:|:----:|--------------------------|
|DLBCL |1   |high-confidence DLBCL gene|
|MCL   |1   |high-confidence MCL gene  |

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source        |frequency (%)|
|:------:|:--------------:|:-------------:|
|DLBCL |GAMBL genomes |3.82         |
|DLBCL |Schmitz cohort|5.74         |
|DLBCL |Reddy cohort  |2.90         |
|DLBCL |Chapuy cohort |3.42         |
|MCL   |GAMBL genomes |2.84         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |2.702           | 0.000          |
|DLBCL |No  |Yes                  |8.732           |58.269          |
|FL    |No  |No                   |0.000           |46.628          |


> [!NOTE]
> First described in DLBCL in 2016 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/26647218). First described in MCL in 2020 by [Pararajalingam P](https://pubmed.ncbi.nlm.nih.gov/32160292)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/NFKBIE_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/NFKBIE_protein_hg38.html)

![image](images/proteinpaint/NFKBIE_NM_004556.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/NFKBIE.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/NFKBIE_hg38.html)

![image](images/proteinpaint/NFKBIE.svg)

## NFKBIE Expression
![image](images/gene_expression/NFKBIE_by_pathology.svg)

## References
1. *Mansouri, L., Noerenberg, D., Young, E., Mylonas, E., Abdulla, M., Frick, M., Asmar, F., Ljungström, V., Schneider, M., Yoshida, K., Skaftason, A., Pandzic, T., González, B., Tasidou, A., Waldhueter, N., Rivas-Delgado, A., Angelopoulou, M., Ziepert, M., Arends, C., Couronné, L., Lenze, D., Baldus, C., Bastard, C., Okosun, J., Fitzgibbon, J., Dörken, B., Drexler, H., Roos-Weil, D., Schmitt, C., Munch-Petersen, H., Zenz, T., Hansmann, M., Strefford, J., Enblad, G., Bernard, O., Ralfkiaer, E., Erlanson, M., Korkolopoulou, P., Hultdin, M., Papadaki, T., Grønbæk, K., López-Guillermo, A., Ogawa, S., Küppers, R., Stamatopoulos, K., Stavroyianni, N., Kanellis, G., Rosenwald, A., Campo, E., Amini, R., Ott, G., Vassilakopoulos, T., Hummel, M., Rosenquist, R., & Damm, F. (2016). Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.. Blood, 128 23, 2666-2670 . https://doi.org/10.1182/BLOOD-2016-03-704528.*
2. *Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020 Jul 30;136(5):572-584. doi: 10.1182/blood.2019002385. PMID: 32160292; PMCID: PMC7440974.*